On October 19, 2009, the U.S. Patent and Trademark Office released a “Notice of Change to Docketing of Requests for Continued Examination.” The Notice indicated that requests for continued examination (RCEs) filed on or after November 15, 2009 will be placed on the examiner’s “Special New” application docket instead of the examiner’s amended docket. An […]

The Biotechnology Industry Organization (BIO) hosted a U.S./China Biotechnology Examiner Workshop with U.S. Patent and Trademark Office (PTO) and China’s State Intellectual Property Office (SIPO) on March 28, 2011 in Beijing, China. The workshop which was organized by BIO for SIPO examiners, focused on biotechnology patenting and encouraged bilateral cooperation between SIPO and the USPTO. […]

A two-day “Invention Analysis and Claiming” seminar is being offered this May in New York (May 12-13), Chicago (May 16-17) and Santa Clara (May 19-20). The program is based on the book “Invention Analysis and Claiming: A Patent Lawyer’s Guide” published by the ABA. The program presents strategic approaches for analyzing inventions and claiming them […]

HCBC and BioStart are seeking early stage, technology focused entrepreneurs who are in need of assistance in building their business and their business plan.  They are offering a 10-week program called Kauffman FastTrac® TechVentureâ„¢. This is the second offering of this program locally.  They offered this program in the Fall of 2010, and successfully graduated […]

After filing a series of five continuation-in-part (“CIP”) applications, which added new matter , a patent finally issued containing claims covering Abbott’s antibody.  Centocor then relied on the added material as evidence of written description to support later asserted claims. The Federal Circuit poo-poohed the idea saying that PTO guidelines prevent claiming a high affinity, […]

Article 229-C of the Brazilian IP Law establishes the need of a “prior approval” by the Agência Nacional de Vigilância Sanitária – ANVISA (the Brazilian regulatory agency responsible for the approval of drugs) – for the issuance of a patent in the pharmaceutical area. This requirement was introduced by the Brazilian Law No. 10.196 of […]

It looks like The Patent Reform Act of 2011 (not to be confused with the the Patent Reform Act of 2010, 2009, 2008, 2007 …) will be on the Senate floor for an up-or-down vote in the next week or so. So, is it good for American inventors or bad?  It depends on whose interest […]

In a paper published by the Washington Legal Foundation, entitled Supreme Court To Address Standard For Induced Patent Infringement, Brian Pandya of Wiley Rein LLP present an examination of Global-Tech Appliances Inc. v. SEB, S.A. The U.S. Supreme Court will hold oral argument in the case today. The Supreme Court has ruled in nine patent […]